Atlas Trials

Non-Alcoholic Fatty Liver Disease

513 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Non-Alcoholic Fatty Liver Disease

RecordFirmDate
Evaluation of Lipid Profile in Different Grades of Non-alcoholic Fatty Liver Disease Diagnosed by Ultrasound (NCT05486429)Sohag University2022-07-20
To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation (NCT05402449)GenMont Biotech Incorporation2022-07-14
Ursodeoxycholic Acid in Patients With NAFLD - Clinical Observation (NCT05256979)General University Hospital, Prague2022-07-02
A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease (NCT05426382)Sidekick Health2022-06-20
Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLD (NCT05766449)The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2022-06-01
A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH (NCT03970031)Cirius Therapeutics, Inc.2022-06-01
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease (NCT06348628)Madunil Anuk Niriella2022-05-31
Healthy Liver - Healthy Brain (NCT05216796)University of Texas at Austin2022-05-18
Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease (NCT05200585)The University of Texas Health Science Center, Houston2022-05-11
To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease (NCT05858138)Taichung Tzu Chi Hospital2022-05-03
Moderately Carbohydrate-restricted Diet to Treat NAFLD in Adolescents (NCT05268042)University of Alabama at Birmingham2022-05-01
Liver Fat Content and Bariatric Surgery (NCT06064240)yu li,MD2022-05-01
Fecal Microbiota Transplantation for the Treatment of Non-Alcoholic Steatohepatitis (NCT03803540)Puerta de Hierro University Hospital2022-05-01
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease (NCT05332613)Weill Medical College of Cornell University2022-04-27
Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression (NCT05291104)Fu Jen Catholic University Hospital2022-04-25
BeijngFH Health Cohort Study (NCT05546086)Beijing Friendship Hospital2022-04-18
Prevention of NAFLD in Hispanic Children (NCT05292352)Emory University2022-04-06
Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD) (NCT05292911)Altimmune, Inc.2022-03-09
Lysosomal Acid Lipase Activity in Nonalcoholic Fatty Liver Disease (NCT05419765)University of Roma La Sapienza2022-03-01
UDFF Performance Evaluation ((Ultrason Derived Fat Fraction) (NCT06080386)University Hospital, Angers2022-03-01
Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals (NCT05245890)Ningbo No. 1 Hospital2022-03-01
Effect of Adjustable Intragastric Balloon in Obese Non-alcoholic Fatty Liver Disease (NCT04182646)Asian Institute of Gastroenterology, India2022-02-25
Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease (NCT05209100)AdventHealth Translational Research Institute2022-02-11
Impact Of Choline in Patients With NAFLD (NCT05200156)Ain Shams University2022-02-01
Intermittent Fasting for NAFLD in Adults (NCT04899102)Massachusetts General Hospital2022-02-01
Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients (NCT05474560)Ain Shams University2022-01-01
Electrical Impedance Tomography in Fatty Liver Detection (NCT05189990)The University of Hong Kong2022-01-01
Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver Patients (NCT06666894)Cairo University2022-01-01
Serum Adiponectin as an Early Marker for Renal Impairment in Patients With Non-alcoholic Fatty Liver Disease. (NCT05106049)Assiut University2021-12-01
A Clinical Trial of XZP-6019 Tablets in Healthy Subjects (NCT05063968)Xuanzhu Biopharmaceutical Co., Ltd.2021-11-30
Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD) (NCT04969744)Guy's and St Thomas' NHS Foundation Trust2021-10-23
Non-Alcoholic Fatty Liver Disease and Anthropometric Measurements (NCT05810506)Bandırma Onyedi Eylül University2021-10-01
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD) (NCT05006885)Altimmune, Inc.2021-09-30
Prevention of NAFLD and CVD Through Lifestyle Intervention (NCT05618626)Pontificia Universidad Catolica de Chile2021-09-27
Clinical Trials Using HepatoKeeper Herbal Essentials to Treat Non-alcoholic Fatty Liver Disease and Metabolic Factors (NCT06244550)Taipei City Hospital2021-09-22
Non-invasive Ultrasound Diagnosis of Chronic Liver Diseases in Hepatology Consultation (NCT04782050)E-Scopics2021-09-15
Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus (NCT05054712)Consorci Sanitari de l'Alt Penedès i Garraf2021-09-01
Ectopic Fat in Singaporean Women - the Culprit Leading to Gestational Diabetes, Metabolic Syndrome, and Type 2 Diabetes (TANGO Study) (NCT05259475)Institute for Human Development and Potential (IHDP), Singapore2021-08-20
Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD (NCT07378280)Chuncheon Sacred Heart Hospital2021-08-18
Effect of F. Prausnitzii on Glycemic Control (NCT04938843)MetaboGen AB2021-08-16
MLCT Oil for Fatty Liver - PASS Trial (NCT05217745)National University Hospital, Singapore2021-08-05
Impact of FMT on the Phenome in Patients With NAFLD and Fibrosis (NCT06024681)Imperial College London2021-07-20
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) (NCT04951219)Madrigal Pharmaceuticals, Inc.2021-07-09
Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease (NCT05728697)Brigham and Women's Hospital2021-06-01
Development and Evaluation of a Glucagon Sensitivity Test in Individuals With and Without Hepatic Steatosis (NCT04907721)University of Copenhagen2021-05-27
Effects of Aerobic Exercise on Lean Non-alcoholic Fatty Liver Disease (NAFLD) (NCT04882644)The First Affiliated Hospital with Nanjing Medical University2021-05-14
Study in Healthy Adults Evaluating PF-07202954 (NCT04857437)Pfizer2021-05-13
Effect of L-Citrulline Supplementation on NAFLD in Adolescents With Obesity (NCT04871360)Universidad de Guanajuato2021-05-05
"CAP" Fetge Gras. Lifestyle Modification Program in Catalonia. (NCT04988633)Hospital Clinic of Barcelona2021-05-01
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL) (NCT04807868)AdventHealth Translational Research Institute2021-04-22
Effects of High-Intensity Interval Training Exercise in Adolescents With Hepatosteatosis (NCT04342390)Arkansas Children's Hospital Research Institute2021-04-02
Dairy Protien Rich Diet for NAFLD Patients (NCT04841915)University of Aarhus2021-03-15
Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study (NCT04800094)Philips Clinical & Medical Affairs Global2021-03-02
Economic Burden of NAFLD (NCT05035043)Hasselt University2021-03-01
Effect of Alpha Lipoic Acid on Non-alcoholic Fatty Liver Diseases (NCT04475276)All India Institute of Medical Sciences, Bhubaneswar2021-02-23
Study of Semaglutide for Non-Alcoholic Fatty Liver Disease (NAFLD), a Metabolic Syndrome With Insulin Resistance, Increased Hepatic Lipids, and Increased Cardiovascular Disease Risk (The SLIM LIVER Study) (NCT04216589)National Institute of Allergy and Infectious Diseases (NIAID)2021-02-19
The Effect of Lifestyle-induced Hepatic Steatosis on Glucagon-stimulated Amino Acid Turnover (NCT04859322)Malte Palm Suppli, MD2021-02-08
Early Vascular Ageing in the YOUth (NCT04598685)VASCage GmbH2021-02-01
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases". (NCT04690972)Institut National de la Santé Et de la Recherche Médicale, France2021-01-14
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD. (NCT04579874)Fibronostics USA, Inc2021-01-07
Effect of Empagliflozin on Liver Fat in Non-diabetic Patients (NCT04642261)The University of Hong Kong2021-01-01
Exercise and Cerebral Hemodynamics in MAFLD. (NCT05520697)Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2020-12-01
Influence of the Diversity and Composition of the Microbiota in the Development of Pediatric Fatty Liver (NCT04575506)Universidad Pública de Navarra2020-11-16
Demonstration of the Prebiotic-like Effects of Camu-camu Consumption Against Obesity-related Disorders in Humans (NCT04130321)Laval University2020-10-31
Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study (NCT04657523)Philips Clinical & Medical Affairs Global2020-10-30
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology. (NCT04435054)Hospices Civils de Lyon2020-10-28
Screening for NAFLD in Flanders (NCT04647409)Hasselt University2020-10-26
Integrated Diagnostics for Early Diagnosis of Liver Disease (NCT04666402)Manchester University NHS Foundation Trust2020-10-21
Micro RNA Levels in NAFLD (NCT04574557)Assiut University2020-10-15
Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver Disease (NCT04594954)Institute of Liver and Biliary Sciences, India2020-10-15
Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease (NCT06596382)National University of Malaysia2020-10-13
The Olmsted NAFLD Epidemiology Study (TONES) (NCT04365855)Mayo Clinic2020-10-10
Multicenter Registry of Nonalcoholic Fatty Liver Disease (NCT04540731)Hospital Italiano de Buenos Aires2020-10-01
Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH (NCT04555434)Chuncheon Sacred Heart Hospital2020-09-20
Role of Probiotics in Treatment of Pediatric NAFLD Patients by Assessing With Fibroscan (NCT04671186)Northwell Health2020-09-07
The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects (NCT04422496)Sunshine Lake Pharma Co., Ltd.2020-08-10
Multi-Parametric MRI Assessment of the Liver in the Dallas-FortWorth Metroplex Population (NCT04336618)Perspectum2020-08-03
Predicting Obesity Consequences Using Body Measure and Urine Metabolomics (NCT04989062)Chang Gung Memorial Hospital2020-08-01
Hyperpolarized Pyruvate (13C) Magnetic Resonance Imaging In Patients With Fatty Liver Disease (NCT06176079)Michael Ohliger, MD PhD2020-07-22
Alternation of Non-alcoholic Fatty Liver Disease (NAFLD) and Cardiovascular Risks After Liftestyle Modification: A Ultrasound Attenuation Imaging-Based Study (NCT04440540)Chinese University of Hong Kong2020-07-02
Study of Various Treatments in Non-alcoholic Fatty Liver Disease (NAFLD) Patients Who Have Aspects of Non-alcoholic Steatohepatitis (NASH) (NCT04147195)Novartis Pharmaceuticals2020-06-04
Effect of Molecular Hydrogen in Patients With NAFLD (NCT05325398)Comenius University2020-05-01
Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease (NCT05563259)Yan Bi2020-05-01
Multi-Parametric MRI Assessment of the Liver in Diabetic Volunteers (Partners Registry) (NCT04336800)Perspectum2020-04-01
MRI and Stable Isotope Tracer Studies for Detecting the Progression of Non-Alcoholic Steatohepatitis (NASH) (NCT04227782)University of Oxford2020-03-01
A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD) (NCT04237116)Novartis Pharmaceuticals2020-02-19
Endoscopic Gastric Plication Using the POSE2.0 Technique for Management of Fatty Liver Disease (NCT05611567)Emirates Health Services (EHS)2020-01-20
Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) (NCT04198805)Naga P. Chalasani2020-01-03
Characteristics of NAFLD Among Type 2 Diabetes Patients (NCT04999124)Ziekenhuis Oost-Limburg2020-01-01
Sulforaphane Supplementation Study (NCT04364360)University of Oxford2020-01-01
Mediterranean Diet Versus Paleolithic Diet for the Treatment of Non Alcohlic Fatty Liver Disease (NCT04400864)Rabin Medical Center2019-12-30
A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Non Alcoholic Fatty Liver Disease Patients (NCT04197479)Madrigal Pharmaceuticals, Inc.2019-12-16
Weight Loss in Adults With Obesity Using a Combination of Low Energy Diet, Group Treatment and Intragastric Balloon (NCT04230655)Region Örebro County2019-12-10
The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance (NCT04315350)University Hospital, Gentofte, Copenhagen2019-12-01
Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis (NCT04142749)PharmaKing2019-11-15
NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal (NCT03864835)Milton S. Hershey Medical Center2019-11-01
Hybrid Training and Middle Age (NCT05231564)University of Sistan and Baluchestan2019-11-01
Glucagon Resistance in Patients With NAFLD (NCT04042142)University of Aarhus2019-10-05
Silymarin in NAFLD (NCT02973295)University Hospital Rijeka2019-09-20
NAFLD Study: US vs Liver Biopsy (NCT04101162)University of Roma La Sapienza2019-09-15
Next →

Track Non-Alcoholic Fatty Liver Disease automatically

Every clearance here is in the API, with alerts when new ones post.